Ocugen, Inc. — Investor Relations & Filings
Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-14 | English | |
| FORM 8-K | 2026-05-14 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | |
| ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | |
| SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46257527 | FORM 8-K | 2026-05-14 | English | ||
| 46289439 | FORM 8-K | 2026-05-14 | English | ||
| 41428961 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | ||
| 41043585 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | ||
| 37961514 | ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | ||
| 33062206 | SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English | ||
| 33033584 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-24 | English | ||
| 32998803 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-20 | English | ||
| 32890785 | 10-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890779 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890780 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 29170586 | 8-K Filing | 2026-02-09 | English | ||
| 29170562 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 29170569 | 8-K Filing | 2026-01-23 | English | ||
| 29170585 | 8-K Filing | 2026-01-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
Ocugen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32915/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32915 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32915 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32915 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32915}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ocugen, Inc. (id: 32915)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.